David Southwell

And we are a business.

And pharma companies trade on a multiple of earnings, so they don't want to do

a lot of early stage research.

They want to buy a product with low risk and market it using their extensive sales force.

We're developing drugs.

How do you kind of blend those two?

And we did that a little bit at SepraCore because we had products on the market.

But it's a very, very difficult challenge to go from being a science company to being a commercial company.

It requires a completely different set of skills.

And it would be really interesting to talk to more people that have done it

You know, I'm thinking of John Maragonori as the perfect example of that at Allen Island, but also Alexion.

I mean, same thing.

There aren't that many people that have done it.

I really appreciate it.

This was a very enjoyable conversation.